Research examines whether financial challenges facing hospitals with large Medicare populations lead indirectly to cost shifting
Harvard researchers found evidence to suggest that hospitals with large shares of Medicare patients are at greater risk of being acquired, which can skew the market structure and lead to higher commercial prices.
Study: In price negotiations with hospitals, self-insured employers lack leverage
The vast difference in market power between hospitals and employers leaves the latter group with little recourse in negotiations, according to a new study.
Moving a 340B covered entity’s pharmacy enterprise to an LLC may prove beneficial, but it requires a feasibility study
University of Utah Hospitals and Clinics (UUHC) in Salt Lake City performed research to assess the feasibility of moving its 340B covered-entity pharmacy enterprise to a Limited Liability Corporation (LLC), with a focus on risks that should be factored into the decision. Other organizations that are considering such a move could benefit from adopting UUHC’s assessment approach.
Healthcare News of Note: More healthcare organizations mandating that employees receive the COVID-19 vaccine
Healthcare News of Note for healthcare finance professionals is a roundup of recent news articles: COVID-19 vaccine mandates become more popular among healthcare organizations, hospitals continue to skirt price transparency rules, and healthcare workers get help in coping with trauma.
Hospitals not adhering to CMS’s cost transparency rule may eventually find their public images tarnished by their noncompliance
Hospitals could lose patients and their good reputations if CMS makes public the names of those noncompliant with the latest price transparency rule.
Congress seeks stepped-up hospital price transparency enforcement as compliance issues continue to emerge
The bipartisan leadership of a congressional committee is urging HHS to enforce price transparency rules more stringently.
3 questions with Katie Gilfillan: Why it’s time for the healthcare industry to address cost effectiveness of health
HFMA’s director of professional practice and clinical relationships discusses the importance of the Association’s Cost Effectiveness of Health event.
HHS delays implementation of rule requiring FQHCs to provide insulin, epinephrine at 340B prices
HHS has postponed a Trump administration regulation that would require federally qualified health centers to make certain drugs more affordable for low-income patients and will consider whether to withdraw the rule altogether.
How a health system prepared to comply with CMS’s new price transparency rule
The efforts of one health system to meet state and federal price transparency regulations shows the benefit of integrating transparency efforts into a broader organizational strategy.
SVP Rick Gundling recaps new workshops, Biden and surprise bills
Rick Gundling, HFMA’s senior vice president of professional practice, talks about the Association's education plans for 2021 and comments on some hot topics in healthcare.